Showing results (171-180 of 270) with videos related to

Sort By:
Pageof 27
Blood|July 26, 2015
Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodiesZhi-Jian Liu, James B Bussel, Madhavi Lakkaraja, et al.
Transfusion|July 4, 2019
Pathogen reduced plasma products: a clinical practice scientific review from the AABBMelissa M Cushing, Monica B Pagano, Jessica Jacobson, et al.
British Journal of Haematology|January 13, 2021
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopeniaRalph Boccia, Nichola Cooper, Waleed Ghanima, et al.
American Journal of Hematology|November 13, 2018
Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND studyAbderrahim Khelif, Mansoor N Saleh, Abdulgabar Salama, et al.
British Journal of Haematology|November 18, 2024
Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double-blind, placebo-controlled phase 3 studies and their open-label extensionNichola Cooper, James B Bussel, Maciej Kaźmierczak, et al.
Blood|February 2, 2012
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activationBethan Psaila, James B Bussel, Matthew D Linden, et al.
Transfusion|December 21, 2021
Safety and tolerability of solvent/detergent-treated plasma for pediatric patients requiring therapeutic plasma exchange: An open-label, multicenter, postmarketing studyCassandra D Josephson, Stuart Goldstein, David Askenazi, et al.
Blood|April 20, 2011
A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopeniaJames B Bussel, George R Buchanan, Diane J Nugent, et al.
Transfusion|April 17, 2014
A comparison of adverse reaction rates for PAS C versus plasma platelet unitsClaudia S Cohn, James Stubbs, Joseph Schwartz, et al.
Platelets|March 20, 2019
Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonistsLamya Garabet, Waleed Ghanima, Anbjørg Rangberg, et al.
Pageof 27